Arthur Spiegel
Arthur Spiegel is an entrepreneur with more than 35 years experience in healthcare. Formerly President of Computer Sciences Corporations (CSC) Healthcare Group and of APM Inc., he is co-founder and Co-Chairman of Accretive Health Inc., sits on the Boards of EyeTel Imaging Inc., Broadlane Inc., Silverlink, Lynx Medical Systems, is Chairman of MDeverywhere, Inc. and is the former Chairman of the Board of Amicas, Inc., recently sold to Vital Works Inc.
Spiegel founded APM Management Consultants in 1974 and grew the firm into the nation’s largest stand-alone consulting firm dedicated to healthcare. In 1996, he sold APM to CSC, where, as President reporting to the CEO, he established and built the CSC Healthcare Group into one of the top four technology service companies in the industry. Serving health plans, providers, and life sciences companies, the group provided leading-edge consulting and systems integration services, claims processing software, business process outsourcing for health plans, and IT outsourcing throughout the healthcare industry. He retired from CSC in 2002.
Prior to founding APM, Spiegel held top management roles in New York City’s Housing and Development and Human Resources agencies and was one of the early leaders of Accion en Venezuela (now Accion International), a corporately-funded community development organization.
He has served on numerous boards in the past, including as President of The New York chapter of the March of Dimes, and Secretary of the National Center for Health Education. He has published in business journals including the Harvard Business Review and was named ‘One of the Most Influential Individuals in Health Care IT’ by the leading trade publication, Advance for Health Information Executives (1999).
Spiegel holds an MBA from the Harvard Business School and a BA from Stanford University.
Bill Williams
Bill Williams is a Special Venture Partner with Galen Partners. Galen Partners is one of the largest and most influential private equity investment firms focused solely on the healthcare industry.
Williams was President of Pyxis Corporation from 1996-1998. He joined Pyxis in 1988 as the second employee and its Vice-President of Marketing and Sales. Later he would serve as Vice-President of Sales & Sales Operations, Senior Vice-President, and Executive Vice-President. He was foundational to the early stage market research, strategic planning, organizational structure, product development, M & A activity, and capital formation of the company. He was a central figure in the development of the Pyxis value based corporate culture and service oriented sales strategies. He played a prominent role in guiding Pyxis to one of the nation’s most successful public offerings in 1992, and eventually a billion dollar merger with Cardinal Health, an S&P 500 company, in 1996.
Prior to joining Pyxis, Williams had twenty years of healthcare experience that included staff and line management positions with Johnson & Johnson, Zimmer USA, Howmedica, and DePuy, Inc. During those years he was involved with the development and market introduction of numerous medical devices, capital goods, services, and software applications to the healthcare marketplace.
Williams is the founder and President of Faranhyll Foundation, Inc., whose charter is to foster value-based leadership in corporate life. He is a frequent speaker and seminar leader addressing such topics as leadership, mentoring, marketing & sales strategies, and corporate culture development. He is the author of the non-fiction book, Wrestling with Destiny.
He graduated from The University of Missouri in 1970 with a Bachelor of Arts degree.
Jason Fisherman, M.D.
Dr. Fisherman is a Managing Director of Advent International, a global private equity firm where he specializes in healthcare and biopharmaceutical investments. He joined the firm in 1994. From 1991 to 1994, Dr. Fisherman served as Senior Director of Medical Research for Enzon, Inc., a biopharmaceutical company, and previously managed the clinical development of a number of oncology drugs at the National Cancer Institute. Dr. Fisherman is currently a director of several private healthcare companies.
Dr. Fisherman received his B.A. from Yale University, his M.D. from the University of Pennsylvania and his M.B.A. from the Wharton School of the University of Pennsylvania.
Tom Needham
Tom Needham joined Advent in 2002 and has 11 years of operating experience in biotechnology and corporate business development. He focuses on investments in the biotechnology and emerging pharmaceutical sectors.
Prior to joining Advent he most recently was vice president of business development for the US operations of GPC Biotech, a Germany-headquartered drug discovery and development company. Needham 's affiliation with Advent began in 1994, when he was vice president of business development for Mitotix Inc., an Advent portfolio drug-discovery company focused on cancer and infectious disease. Mitotix later merged with GPC Biotech AG, which completed an IPO in 2000. While at GPC Biotech and Mitotix, Needham held senior management responsibilities in corporate and business development, in-licensing and out licensing, which included involvement in negotiating and closing R&D collaborations with pharma valued in excess of $250 million. Prior to Mitotix, he was at ImmuLogic Pharmaceutical in marketing and business development. Needham led and co-manages Advent's investment in Spherics, Inc.
He received a BA degree, cum laude, from Bowdoin College and an MBA, with high distinction, from Babson College's Olin School of Management.
Douglas Present
Douglas Present is currently the Chairman & CEO of Managed Health Care Associates, Inc. (MHA). MHA is the largest Group Purchasing Organization in the country focused on alternate site/non-acute settings with over $3 billion in pharmaceutical sales to these providers. Under Present’s leadership over the last five years, MHA has grown its revenue and earnings 300% and 500% respectively. Present also engineered the sale of MHA from Advent International to GTCR in the summer of 2004.
Before joining MHA, Present was Senior Vice President of Medsite, Inc., a pharmaceutical services and e-marketing company, where he ran the Medsite Rewards program, the nation’s leading physician incentive-fulfillment program for the pharmaceutical industry. Medsite was acquired by WebMD in 2006.
Earlier in his career, Present founded a physician-focused, managed care consulting firm as well as a group purchasing organization for private practice physicians. Both companies were subsequently acquired by ProMedCo, a physician management company. After the acquisition, he served as President and COO of ProMedCo’s New York subsidiary.
Present graduated from The Wharton School at the University of Pennsylvania in 1990 with an MBA in Finance and spent three years in the New York health care consulting practice of Deloitte & Touche. In addition to his current role at MHA, Present sits on the Board of Directors of American Radiology Services, Inc. and MDeverywhere, Inc.
|
